GRAL
GRAIL Inc. · Healthcare · Medical - Diagnostics & Research
Momentum-inputs (vergelijkbare managers):
breedte van houders +20.0% ·
aandelenstroom +9.0% ·
netto nieuwe posities +16.7%
— formule
Brede accumulatie — stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 111 | +3 | 19.70M | $1.34B | +13 | −9 |
| Q1 2026 | 110 | -6 | 18.56M | $959.35M | +4 | −11 |
| Q4 2025 | 117 | +2 | 17.78M | $1.52B | +3 | — |
| Q3 2025 | 18 | +1 | 10.99M | $649.07M | +2 | −2 |
| Q2 2025 | 15 | -1 | 10.50M | $537.63M | +1 | −2 |
| Q1 2025 | 13 | +1 | 6.08M | $155.14M | +2 | −1 |
| Q4 2024 | 12 | +2 | 5.32M | $94.90M | +3 | −1 |
| Q3 2024 | 9 | -6 | 3.74M | $51.49M | — | −6 |
| Q2 2024 | 15 | — | 4.39M | $67.54M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | PRIMECAP Management ✦ | 2.08M | -4.7% | $37.12M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (passief) | 1.14M | — | $20.29M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | AQR Capital Management ✦ | 830.72K | +71.0% | $14.83M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | AQR Capital Management ✦ | 830.72K | +71.0% | $14.83M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 830.72K | +71.0% | $14.83M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passief) | 443.56K | +4.6% | $7.92M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passief) | 443.56K | +4.6% | $7.92M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Millennium Management ✦ | 295.52K | +41.8% | $5.28M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 282.84K | +295.8% | $5.05M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 282.84K | +295.8% | $5.05M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 96.63K | Nieuw | $1.72M | 0.0% | New | 1 | SEC ↗ |
| 12 | Norges Bank ✦ (passief) | 66.34K | 0.0% | $1.18M | 0.0% | Held | 3 | SEC ↗ |
| 13 | GAMCO Investors ✦ | 25.90K | -2.6% | $462,315 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 24.52K | +21.7% | $438,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Wellington Management ✦ | 22.86K | Nieuw | $408,051 | 0.0% | New | 1 | SEC ↗ |
| 16 | Arrowstreet Capital ✦ | 11.50K | Nieuw | $205,293 | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Two Sigma Investments | $1.72M | 0.0% |
| Wellington Management | $408,051 | 0.0% |
| Arrowstreet Capital | $205,293 | 0.0% |
Verlaten
| Marshall Wace | $3.53M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1 houders, 9.40K aandelen, $485 gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.